Westchester Medical Center
Locations
Transplant Summary
Overview
The BMT/Stem Cell service is the oldest transplant program in New York State, beginning its allogeneic transplant program in 1983. The program was granted FACT reaccreditation in April 2007, October 2010, April, 2014, October 2017 and June 2021. In addition to performing both Autologous and Allogeneic stem cell transplants, we also perform haploidentical transplants from related donors. We also have the ability to manufacture on site Cytotoxic T Lymphocytes to fight CMV, EBV, Adenovirus and BK virus.This center has been performing allogeneic transplants since 1983 and has been an NMDP transplant center since September 1994.
Attending physicians
Adult - Allyson Flower, DeLong Liu, Karen Seiter, Amir Steinberg
Pediatric - Mitchell Cairo, Aliza Gardenswartz, Jessica HochbergTransplants performed
Marrow/PBSC, single cord, and double cordCord blood transplants
Adult and pediatricOther programs and services
We manufacture and administer cytotoxic T lymphocytes (CTL's) for viral infections (Adeno, CMV, EBV, BK) and recently became an authorized treatment center for CAR T Cell Therapy.Patient survival information for this center
This center's actual 1-year survival results are below the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 38 patients.The actual 1-year survival of these patients is 68.4%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 73.5% and 94.5%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
35
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow0PBSC4Cord blood0Total4Unrelated donorMarrow0PBSC5Cord blood0Total5Total allogeneicMarrow0PBSC9Cord blood0Total9AutologousMarrowBoth marrow & PBSC 26PBSC—Cord blood—Total26Total combinedMarrowBoth marrow & PBSC 35PBSC—Cord blood0Total35Total pediatric transplants
25
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow4PBSC6Cord blood0Total10Unrelated donorMarrow0PBSC1Cord blood1Total2Total allogeneicMarrow4PBSC7Cord blood1Total12AutologousMarrowBoth marrow & PBSC 13PBSC—Cord blood—Total13Total combinedMarrowBoth marrow & PBSC 24PBSC—Cord blood1Total25All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-181019-44345-64165+0Total14Unrelated 0-18219-44145-64365+1Total7Autologous 0-181319-44245-641665+8Total39Total 0-182519-44645-642065+9Total60Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
Transplant center coordinatorSandra FabricatorePhone: (914) 594-2152If you have questions about costs and financial services at this center, please call the transplant center’s direct phone number.NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
Wellness and Survivorship Program
Wellness and Survivorship Program19 Bradhurst Avenue, Suite 800S Hawthorne, NY 10532 Phone:914-493-7997 Physician Referrals:914-614-4270 Email:jessica.hochberg@wmchealth.org For more information about this program: https://www.wmchealth.org/service-line/pediatric-services/pediatric-hematology-oncology (Opens in a new tab)Overview
This program specializes in following patients who have completed treatment for cancer or are recipients of a blood or bone marrow transplant. Our program manages their long-term follow-up care through a multidisciplinary team of providers knowledgeable in the existing research on late-effects in survivors. The Wellness & Survivorship program is designed to be a yearly clinic visit which promotes wellness, provides proper resources, and maintains a supportive environment. At each visit, the patient will meet with an oncologist, nurse practitioner, social worker, and neuropsychologist, receive a physical examination and brief social and neuropsychological assessments, and be provided with prescriptions for blood work and routine screening tests based on their cancer history and treatment regimen. Patients also receive a personalized Survivorship Care Plan, which summarizes the major parts of their treatment as well as the current guidelines for follow-up. The care plan recommendations are based on guidelines published by the Children's Oncology Group and are specific to the types of therapy received.
Staff
Program Director:Jessica Hochberg, MDProgram Coordinator:Brittany Huber, RN, MSN, FNP-CMedical Specialties in Program
Allergy/immunology, cardiology, complementary and alternative medicine, dermatology, endocrinology, gastroenterology, gynecology, hematology, hepatology, infectious disease, nephrology, neurology, oncology, ophthalmology/optometry, otolaryngology, psychiatry/psychology, pulmonology, rheumatology, urology.Medical Services Offered
Chronic GVHD management, fertility counseling, reproductive health, financial counseling, genetic counseling, nutrition/dietetics, occupational therapy, pain management, physical therapy and rehabilitation, sexual health, social services.Telemedicine services are available.Patient Eligibility
Children- Allogeneic and Autologous transplant recipients
- Minimum of 5 years after transplant.
- Patients who were transplanted as a child at this center with no upper age limit
- Does accept patients who were transplanted at another hospital
- Will admit pediatric patients who transferred into the program
- Will accept adult patients who were transplanted as a child at another center